Operator Good afternoon, ladies and gentlemen, and welcome to the Inovio third quarter 2024 financial results conference call. At this time, all lines are in a listen-only mode. Following the presentation,

At this time, all participants are in a listen-only mode. A question-and-answer session will follow the presentation. [Operator instructions] As a reminder, this call is being recorded. Now, I would like to turn the call over to Ed McGregor,

Shares of Inovio Pharmaceuticals ($INO) slipped nearly 2% on Thursday afternoon ahead of the company’s third-quarter results, with retail sentiment staying bullish. Wall Street analysts expect earnings per share (EPS) of around -$1.